BioInformatics, LLC to Present Survey Results at the Mid-Atlantic BIO/MED Conference December 3-4
ARLINGTON, Va., Nov. 24, 2003 - Don't miss the opportunity to hear BioInformatics, LLC's Director of Market Research, Robin Rothrock, Ph.D., and The Science Advisory Board's Director of Scientific and Medical Communications, Tamara Zemlo, Ph.D., MPH, present an overview of twenty recent market studies on topics ranging from cell biology to pharmacogenomics.
The presentation will take place on December 4th from 10 AM to 1 PM at the Mid-Atlantic BIO/MED Conference (http://www.biomedexpo.com) in Baltimore, MD and follows influential keynote speakers that include Mark B. McClellan, M.D., Ph.D. (Commissioner of the FDA), Steven M. Paul, M.D. (President, Lilly Research Laboratories) and William A. Haseltine, Ph.D. (Chairman and CEO, Human Genome Sciences, Inc.).
"Because of the vital role that our clients play in creating the tools and technologies that drive life science research, our presentation at the Mid-Atlantic BIO/MED Conference will help elevate the visibility of the important tools segment of the biotechnology industry." says Bill Kelly, President of BioInformatics, LLC, a leading provider of market research to the life science industry (http://www.gene2drug.com).
In their presentation, Enabling Discovery: The View From the Lab Bench, Rothrock and Zemlo will showcase the experiences and opinions of thousands of biomedical scientists surveyed by BioInformatics, LLC over the last 18 months and provide a "Consumer Reports" look at the companies, instrumentation and consumables that enable cutting-edge research in pharmaceutical, biotechnology and government labs. Their presentation will enable Chief Scientific Officers, R&D Directors, Laboratory Managers and other attendees to benchmark their own R&D against the technology preferences of researchers in the areas of cell biology, drug discovery, genetics, microbiology, molecular biology, pharmacogenomics and proteomics.
Other topics to be addressed at the conference include: bioterrorism, business development, business practicum, clinical testing/trials, drug development, discovery, informatics, policy and the investment community. With an anticipated attendance of more than 2,000 individuals, this conference offers life science companies an excellent opportunity to promote themselves to scientists and researchers in the discovery process, bio and pharma executives in the development process, clinical and medical specialists in the proving process, and other key stakeholders including investors, venture capitalists and service providers.
For more information on attending or exhibiting at the Mid-Atlantic BIO/MED Conference, please contact the conference organizer, E.J. Krause & Associates. To receive a 25% discount on registration fees or a 10% discount on exhibitor fees, please contact Addy Kennedy at E.J. Krause & Associates before December 1st and mention BioInformatics, LLC. Kennedy can be reached by calling 301.493.5500 or sending an email to email@example.com.
ABOUT THE MID-ATLANTIC BIO/MED CONFERENCE
BIO/MED is the premier conference and exhibition targeting the bottlenecks, barriers and business opportunities in the Mid-Atlantic biomedical technology industry. The Mid-Atlantic region represents the United States' strongest concentration of biomedical science research and discovery, pharmaceutical R&D, clinical centers of excellence, and federal legislative and regulatory policy centers.
ABOUT BIOINFORMATICS, LLC
BioInformatics, LLC is a market research firm located in Arlington, Virginia. BioInformatics supports marketing, sales and R&D executives in the life science, medical device and pharmaceutical industries through published research reports, custom research and consulting. BioInformatics sponsors the world's largest market research panel of scientific customers-The Science Advisory Board (http://www.scienceboard.net)-which consists of more than 17,000 scientists, physicians and other life science and medical professionals from 62 countries who participate in surveys that address emerging technologies, test customer reactions to new product concepts, measure brand awareness and assess advertising effectiveness.
FOR MORE INFORMATION, PLEASE CONTACT:
Posted: November 2003